Brian G Feagan Selected Research

Crohn Disease (Crohn's Disease)

11/2022	Responsiveness of Magnetic Resonance Enterography Indices for Evaluation of Luminal Disease Activity in Crohn's Disease.
10/2022	CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
1/2022	Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial.
1/2022	Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's Disease: A Systematic Review.
1/2022	Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
1/2022	Real-world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure-response relationship of vedolizumab in inflammatory bowel disease: ERELATE Study.
1/2022	Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
1/2022	International consensus to standardise histopathological scoring for small bowel strictures in Crohn's disease.
1/2022	Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's Disease.
1/2022	Endoscopic Assessment of Inflammatory Bowel Disease Activity in Clinical Trials.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian G Feagan Research Topics

Disease

147	Crohn Disease (Crohn's Disease) 11/2022 - 01/2002
100	Ulcerative Colitis 10/2022 - 12/2003
63	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022 - 12/2003
25	Infections 01/2022 - 05/2006
18	Necrosis 12/2021 - 12/2011
14	Inflammation (Inflammations) 01/2022 - 05/2007
13	Hemorrhage 01/2022 - 12/2005
11	Neoplasms (Cancer) 01/2022 - 10/2009
10	Body Weight (Weight, Body) 01/2021 - 02/2004
7	Abdominal Pain (Pain, Abdominal) 10/2022 - 12/2008
7	Fistula 02/2019 - 08/2003
6	Rheumatoid Arthritis 01/2019 - 05/2002
5	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 08/2013
4	Pathologic Constriction (Stenosis) 01/2022 - 05/2006
4	Pouchitis 01/2021 - 08/2017
4	Headache (Headaches) 02/2019 - 08/2003
3	Herpes Zoster 03/2022 - 01/2017
3	Abscess 01/2022 - 01/2018
3	Psoriatic Arthritis 01/2022 - 01/2019
3	Fibrosis (Cirrhosis) 01/2022 - 01/2022
3	Arthritis (Polyarthritis) 02/2021 - 01/2018
3	Fatigue 02/2019 - 12/2008
3	Ankylosing Spondylitis 01/2019 - 01/2018
3	Progressive Multifocal Leukoencephalopathy 01/2019 - 11/2005
3	Ulcer 01/2019 - 01/2012
2	Enterocolitis 01/2022 - 01/2022
2	Colitis 01/2022 - 06/2005
2	Erythema Nodosum 02/2021 - 01/2018
2	Eosinophilic Esophagitis 01/2021 - 09/2019
2	Skin Neoplasms (Skin Cancer) 01/2021 - 01/2017
2	Respiratory Tract Infections (Respiratory Tract Infection) 02/2019 - 07/2018
2	Arthralgia (Joint Pain) 01/2019 - 01/2018
2	Chronic Disease (Chronic Diseases) 01/2017 - 12/2008
2	Multiple Sclerosis 01/2016 - 08/2015

Drug/Important Bio-Agent (IBA)

39	vedolizumabIBA 01/2022 - 06/2005
35	Infliximab (Remicade)FDA Link 01/2022 - 05/2002
29	Monoclonal AntibodiesIBA 01/2020 - 02/2004
25	Pharmaceutical PreparationsIBA 10/2022 - 01/2012
24	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 05/2002
22	Tumor Necrosis Factor InhibitorsIBA 02/2021 - 12/2011
19	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2021 - 02/2004
16	Mesalamine (Mesalazine)FDA LinkGeneric 01/2022 - 01/2002
14	Ustekinumab (CNTO 1275)FDA Link 01/2022 - 10/2008
14	IntegrinsIBA 12/2020 - 06/2005
13	Biological ProductsIBA 11/2021 - 11/2008
12	Interleukin-23 (Interleukin 23)IBA 01/2022 - 10/2008
11	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2022 - 11/2008
11	C-Reactive ProteinIBA 10/2022 - 05/2007
10	golimumab FDA Link 01/2020 - 01/2014
9	Phenobarbital (Luminal)FDA Link 11/2022 - 05/2006
8	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 04/2012
8	AntibodiesIBA 11/2021 - 08/2004
8	Interleukin-12 (IL 12)IBA 12/2020 - 10/2008
8	Adalimumab (Humira)FDA Link 05/2020 - 11/2008
7	tofacitinibIBA 01/2022 - 01/2017
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2008
6	risankizumabIBA 01/2022 - 01/2017
6	Certolizumab Pegol FDA Link 01/2022 - 07/2007
6	ozanimodIBA 07/2021 - 01/2016
6	CytokinesIBA 11/2019 - 10/2008
5	Janus Kinase InhibitorsIBA 01/2022 - 01/2017
5	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 01/2002
5	Methotrexate (Mexate)FDA LinkGeneric 08/2014 - 06/2004
5	Sodium Glutamate (Accent)IBA 05/2006 - 05/2002
4	InterleukinsIBA 01/2022 - 12/2012
4	Serum AlbuminIBA 01/2020 - 04/2012
4	Anti-Bacterial Agents (Antibiotics)IBA 02/2019 - 07/2002
4	Natalizumab (Tysabri)FDA Link 01/2016 - 11/2005
4	Azathioprine (Imuran)FDA LinkGeneric 08/2014 - 09/2004
4	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 08/2014 - 09/2004
3	Janus Kinase 1IBA 03/2022 - 01/2020
3	etrolizumabIBA 01/2022 - 07/2014
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
3	AntimetabolitesIBA 01/2018 - 02/2008
3	LactoferrinIBA 07/2017 - 11/2008
3	Narcotics (Narcotic Analgesics)IBA 01/2017 - 05/2006
3	Analgesics (Analgesic Drugs)IBA 01/2017 - 05/2006
3	Metronidazole (Metric)FDA LinkGeneric 01/2009 - 07/2002
3	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2009 - 07/2002
2	GLPG0634IBA 03/2022 - 01/2021
2	mirikizumabIBA 01/2022 - 01/2020
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2021 - 01/2020
2	LipidsIBA 01/2020 - 01/2017
2	upadacitinibIBA 01/2020 - 01/2020
2	Alkaline PhosphataseIBA 01/2020 - 01/2017
2	AlbuminsIBA 01/2020 - 08/2017
2	GED0301IBA 01/2020 - 01/2018
2	Biosimilar PharmaceuticalsIBA 01/2019 - 10/2013
2	secukinumabIBA 01/2019 - 12/2012
2	Janus KinasesIBA 01/2019 - 11/2018

Therapy/Procedure

121	Therapeutics 10/2022 - 01/2002
9	Biological Therapy 01/2022 - 11/2016
9	Remission Induction 12/2020 - 01/2002
5	Drug Therapy (Chemotherapy) 01/2022 - 02/2014
3	Colectomy 10/2021 - 10/2009
2	Liver Transplantation 12/2020 - 05/2019
2	Aftercare (After-Treatment) 01/2020 - 10/2009
2	Restorative Proctocolectomy 10/2018 - 01/2018
2	Precision Medicine 01/2017 - 07/2014
2	Investigational Therapies (Experimental Therapy) 01/2017 - 01/2014